Trade Perrigo - PRGO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 23.81 |
| Open | 23.72 |
| 1-Year Change | -27.99% |
| Day's Range | 23.57 - 23.88 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 16, 2025 | 23.81 | 0.48 | 2.06% | 23.33 | 23.85 | 23.05 |
| Jan 15, 2025 | 23.39 | -0.34 | -1.43% | 23.73 | 23.99 | 23.38 |
| Jan 14, 2025 | 23.47 | -0.51 | -2.13% | 23.98 | 24.16 | 23.08 |
| Jan 13, 2025 | 24.27 | 0.24 | 1.00% | 24.03 | 24.43 | 23.96 |
| Jan 10, 2025 | 24.33 | -0.29 | -1.18% | 24.62 | 24.92 | 24.30 |
| Jan 8, 2025 | 25.02 | 0.38 | 1.54% | 24.64 | 25.03 | 24.17 |
| Jan 7, 2025 | 24.89 | -0.40 | -1.58% | 25.29 | 25.72 | 24.62 |
| Jan 6, 2025 | 25.27 | -0.35 | -1.37% | 25.62 | 25.62 | 23.97 |
| Jan 3, 2025 | 25.90 | 0.07 | 0.27% | 25.83 | 26.24 | 25.64 |
| Jan 2, 2025 | 25.93 | 0.31 | 1.21% | 25.62 | 26.31 | 25.62 |
| Dec 31, 2024 | 25.65 | 0.54 | 2.15% | 25.11 | 25.66 | 25.11 |
| Dec 30, 2024 | 25.24 | -0.16 | -0.63% | 25.40 | 25.41 | 24.84 |
| Dec 27, 2024 | 25.45 | -0.02 | -0.08% | 25.47 | 26.13 | 25.37 |
| Dec 26, 2024 | 25.89 | 0.73 | 2.90% | 25.16 | 26.05 | 25.16 |
| Dec 24, 2024 | 25.56 | 0.20 | 0.79% | 25.36 | 25.67 | 25.36 |
| Dec 23, 2024 | 25.58 | 0.07 | 0.27% | 25.51 | 25.66 | 25.15 |
| Dec 20, 2024 | 25.61 | 0.28 | 1.11% | 25.33 | 26.07 | 25.31 |
| Dec 19, 2024 | 25.66 | 0.25 | 0.98% | 25.41 | 25.75 | 25.08 |
| Dec 18, 2024 | 25.37 | -0.86 | -3.28% | 26.23 | 26.55 | 25.34 |
| Dec 17, 2024 | 26.35 | -0.15 | -0.57% | 26.50 | 26.76 | 26.29 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Perrigo Company profile
About Perrigo Company PLC
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract manufacturing) in the United States (U.S) and Canada. CSCA segment products sold under brands, such as Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees. The CSCI segment comprises consumer self-care business primarily branded in Europe and Australia, store brand business in the United Kingdom and parts of Europe and Asia. The CSCI segment primarily focuses on building local and regional brands sold through merchandisers, drug stores, pharmacies, and e-commerce channels.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Perrigo Company PLC revenues increased 1% to $4.14B. Net loss before extraordinary items totaled $130.9M vs. income of $44.2M. Revenues reflect CSCI segment increase of 4% to $1.45B, CSCA segment remaining flat at $2.69B, Europe segment increase of 3% to $1.39B. Net loss reflects CSCA segment income decrease of 56% to $206.5M. Dividend per share increased from $0.90 to $0.96.
Equity composition
Common Stock no Par, 08/11, 200M auth., 92,797,375 issd. Insiders own 7.05%. IPO: 10/93, 13Mshares @ $31 by J.P. Morgan Securities Inc. 8/93, 2-for-1 stock split. FY'02 & Q's are restated. FY'03 & '04 Summ. Q's reflect the reclassification. FY'04 Q's are reclassified.
| Industry: | Pharmaceuticals (NEC) |
The Sharp Building
Hogan Place
DUBLIN
DUBLIN
IE
News
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com